Loading…
NeurAxis, Inc. is projected to rise to $9.42 by 2027, a +26% move from its current price of $7.45. NRXS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $7.19 | $7.45 | $7.72 | -0.03% |
| May 30 | $7.08 | $7.45 | $7.83 | -0.06% |
| May 31 | $7.00 | $7.44 | $7.91 | -0.09% |
| Jun 1 | $6.93 | $7.44 | $7.99 | -0.13% |
| Jun 2 | $6.87 | $7.44 | $8.05 | -0.16% |
| Jun 3 | $6.82 | $7.44 | $8.11 | -0.19% |
| Jun 4 | $6.77 | $7.43 | $8.17 | -0.22% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $6.77 | $7.43 | $8.17 | -0.22% |
| Week 2 | $6.49 | $7.42 | $8.47 | -0.44% |
| Week 3 | $6.29 | $7.40 | $8.71 | -0.66% |
| Week 4 | $6.12 | $7.38 | $8.91 | -0.87% |
| Week 5 | $5.97 | $7.37 | $9.09 | -1.09% |
| Week 6 | $5.84 | $7.35 | $9.25 | -1.31% |
| Week 7 | $5.72 | $7.34 | $9.41 | -1.52% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
NeurAxis, Inc. is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome, functional dyspepsia and associated FD nausea symptoms.
The company also offers a rectal expulsion device, a screening tool that helps to detect evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. NeurAxis, Inc.
was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
NeurAxis, Inc. (NRXS) is a healthcare company listed with a current price of $7.38 and a market cap of $91.4M. It holds a rank of 4280 in market listings. The latest trading data show a 30-day price range from $5.92 to $9.20. The shares trade in a sector focused on medical technology and neuromodulation therapies within the United States.
A major floor 43.5% below — a decisive break under it would weaken the trend.
The nearest floor, 6.0% below — buyers have tended to step in here.
The nearest ceiling, 18.3% above — a clean break opens room to run.
A major ceiling 28.4% above — clearing it would confirm fresh momentum.
Key NRXS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NRXS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $7.30 | Buy | $7.35 | Buy |
| MA 10 | $7.53 | Sell | $7.51 | Sell |
| MA 20 | $7.87 | Sell | $7.63 | Sell |
| MA 50 | $7.50 | Sell | $7.28 | Buy |
| MA 100 | $6.30 | Buy | $6.40 | Buy |
| MA 200 | $4.56 | Buy | $5.22 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 47.79 | Neutral |
| Stoch RSI (14) | 25.72 | Neutral |
| CCI (20) | -58.77 | Neutral |
| Williams %R (14) | -75.00 | Info |
| MACD (12,26,9) | -0.14 | Sell |
| ROC (12) | -9.15 | Sell |
| Bollinger %B (20,2) | 0.31 | Neutral |
| Stochastic %K (14) | 25.00 | Neutral |
| TRIX (15) | 0.17 | Buy |
| Awesome (5,34) | -0.35 | Sell |
| Ultimate (7,14,28) | 37.75 | Neutral |
| Momentum (10) | -0.82 | Sell |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 7.18 | Buy |
| ADX (14) | 14.88 | Neutral |
| ATR (14) | 0.27 | Info |
Technical sentiment is BULLISH with RSI(14) at 50. The 50-day simple moving average sits at $7.49 while the 200-day simple moving average is $4.52, indicating that price momentum has recently been above the longer-term average. Key near-term levels include support at $6.99 and resistance at $8.81.
Over the last 30 days, the price has moved within a range of $5.92 to $9.20, outlining a backdrop of volatility within a bullish tilt.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.21 | $7.45 | $11.40 | 0% | Neutral | |
| $7.25 | $9.42 | $13.08 | +26% | Bullish | |
| $10.08 | $13.58 | $19.71 | +82% | Bullish | |
| $13.11 | $18.21 | $27.38 | +144% | Bullish | |
| $14.91 | $21.30 | $32.96 | +186% | Bullish | |
| $16.53 | $24.21 | $38.44 | +225% | Bullish | |
| $16.70 | $25.04 | $40.69 | +236% | Bullish | |
| $18.31 | $28.09 | $46.59 | +277% | Bullish | |
| $20.38 | $31.95 | $54.01 | +329% | Bullish | |
| $23.72 | $37.96 | $65.31 | +410% | Bullish | |
| $32.99 | $58.11 | $107.58 | +680% | Bullish | |
| $81.89 | $171.51 | $352.84 | +22.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $4.21 | $7.45 | $8.74 | +0.00% |
| June 2026 | $6.02 | $7.11 | $8.64 | -4.56% |
| July 2026 | $6.06 | $7.24 | $8.95 | +1.82% |
| August 2026 | $6.41 | $7.73 | $9.68 | +6.71% |
| September 2026 | $6.45 | $7.83 | $9.91 | +1.31% |
| October 2026 | $6.45 | $7.88 | $10.08 | +0.71% |
| November 2026 | $6.83 | $8.40 | $10.83 | +6.60% |
| December 2026 | $7.09 | $8.77 | $11.40 | +4.35% |
Click any year to see its month-by-month NRXS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
NeurAxis, Inc.'s 2026 outlook centres on $7.45, within a $4.21 to $11.40 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, NRXS could reach as high as $13.08, with a base case around $9.42 and support toward $7.25 — roughly +26% from $7.45. Buyers look set to stay in control over this stretch.
Expect NRXS to range from $10.08 to $19.71 through 2028. The $13.58 average target implies a +82% move from current prices. That is up +44% on the projected 2027 average. Momentum favours further upside here.
The NRXS price prediction for 2029 points to an average of $18.21 (low $13.11, high $27.38) — a potential gain of +144% on today's $7.45. Buyers look set to stay in control over this stretch.
In 2030, NRXS is projected to trade between $14.91 and $32.96, averaging $21.30 — a potential gain of +186% from today's $7.45. That is up +17% on the projected 2029 average. Momentum favours further upside here.
NeurAxis, Inc.'s 2031 outlook centres on $24.21, within a $16.53 to $38.44 range. That is up +14% on the projected 2030 average. That marks a +225% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, NRXS could reach as high as $40.69, with a base case around $25.04 and support toward $16.70 — roughly +236% from $7.45. Momentum favours further upside here.
Expect NRXS to range from $18.31 to $46.59 through 2033. The $28.09 average target implies a +277% move from current prices. That is up +12% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The NRXS price prediction for 2034 points to an average of $31.95 (low $20.38, high $54.01) — a potential gain of +329% on today's $7.45. Momentum favours further upside here.
In 2035, NRXS is projected to trade between $23.72 and $65.31, averaging $37.96 — a potential gain of +410% from today's $7.45. That is up +19% on the projected 2034 average. Buyers look set to stay in control over this stretch.
NeurAxis, Inc.'s 2040 outlook centres on $58.11, within a $32.99 to $107.58 range. That is up +53% on the projected 2035 average. That marks a +680% change versus current levels. Momentum favours further upside here.
By 2050, NRXS could reach as high as $352.84, with a base case around $171.51 and support toward $81.89 — roughly +22.0x from $7.45. Buyers look set to stay in control over this stretch.
Investing $1,000 in NRXS today (≈ 134.228188 NRXS) could be worth
$23,022.13
+$22,022.13 (+2202%) by 2050 · US Dollar
Based on the average projected NRXS price of $171.51 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NRXSwould be worth at today's price.
$1,000 invested in NRXS on May 27, 2025 (≈ 337.837833 NRXS) would be worth
$2,516.89
+$1,516.89 (+151.7%) today · 2.52× · US Dollar
Based on a NRXS entry price of $2.96 vs. today's $7.45.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.25 | $1,027.59 | +2.8% |
| 1 month ago | $8.13 | $916.36 | -8.4% |
| 3 months ago | $5.69 | $1,309.31 | +30.9% |
| 6 months ago | $2.78 | $2,679.86 | +168.0% |
| 1 year ago | $2.96 | $2,516.89 | +151.7% |
| All time (2.8y) ago | $6 | $1,241.67 | +24.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NRXS forecast.
Our base-case forecast reaches $15.00 around 2029.
Implied market cap at $15.00: $185.77M
The multi-year forecast shows a continued bullish trajectory with rising average prices and sizable returns. In 2026 the average price is forecast at $7.38 (min $4.21, max $11.15) with 0% ROI, followed by a strong ascent in later years. By 2027 the average is $9.21 (min $7.14, max $12.67) with 24.8% ROI, by 2028 $13.17 (min $9.87, max $18.91) with 78.4% ROI, and by 2029 $17.40 (min $12.67, max $25.82) with 135.8% ROI.
In 2030 the average is $20.25 (min $14.37, max $30.91) with 174.4% ROI, rising further to an average of $23.21 in 2031 (min $16.09, max $36.31) and $23.90 in 2032 (min $16.20, max $38.21). By 2033 the average reaches $26.74 (min $17.76, max $43.61) with 262.4% ROI, then $30.50 in 2034 (min $19.85, max $50.66) and $35.30 in 2035 (min $22.54, max $59.62) with 378.3% ROI. The forecast escalates to $55.19 average by 2040 (min $32.26, max $100.03) delivering 647.9% ROI and culminates in 2050 with an average of $155.76 (min $77.81, max $312.57) and 2010.6% ROI.
The sentiment remains BULLISH in the long horizon, acknowledging these are estimates and not guarantees.
Tap a question to reveal the answer.
In 2030, the average forecast price is $20.25 with a minimum of $14.37 and a maximum of $30.91, and a forecasted ROI of 174.4% with a bullish sentiment.
The forecast shows bullish sentiment from 2027 onward with rising average prices (e.g., $9.21 in 2027, $13.17 in 2028, $17.40 in 2029) and improving ROI (e.g., 24.8% in 2027, 78.4% in 2028, 135.8% in 2029). In 2026 the outlook is neutral with an average of $7.38 and 0% ROI.
Yes. The maximum forecast price reaches $100.03 in 2040, with higher maximums projected in later years (e.g., $312.57 in 2050).
The current price is $7.38.
The market capitalization is $91.4M.
NeurAxis, Inc. Community Discussion
0Share your NeurAxis, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.